A new market study, titled “Global Next Generation Cancer Diagnostics Market Size Study, By Technology (NGS, LOAC & RT-PCR), By Application (CTC, Biomarker, Proteomic), By Cancer Type (Lung, Breast), By Function Companion Diagnostics) and Regional Forecasts, 2017-2025”, has been featured on WiseGuyReports.
Global Next Generation Cancer Diagnostics Market is valued approximately USD 5.8 billion in 2016 and is expected to grow at 16.5% CAGR during the forecast period. Owing to the early diagnosis and more précised prognosis of various types of cancer, the next generation cancer diagnostics are gaining faster adoption. Moreover, increasing cases of oncology and advancements in genomics research are primarily driving the market growth.
The objective of the study is to define market sizes of different segments & countries in previous years and to forecast the values to the next eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry with respect to each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as drivers & restraining factors which will define the future growth of the market. Additionally, it will also incorporate the opportunities available in micro markets for stakeholders to invest, detailed analysis of competitive landscape and product offerings of key players.
Global Next Generation Cancer Diagnostics Market to reach USD 14.5 billion by 2025.
The detailed segments and sub-segment of the global infertility treatment market are given below:
Technology:
NGS-based cancer diagnostics
qPCR & Multiplexing
Lab-on- a- chip (LOAC) & Reverse Transcriptase-PCR (RT-PCR)
Protein microarrays-based cancer diagnostics
DNA microarrays-based cancer diagnostics
Type:
Lung Cancer
Breast Cancer
Colorectal Cancer
Cervical Cancer
Others
Applications:
Biomarker Development
CTC Analysis
Proteomic Analysis
Epigenetic Analysis
Genetic Analysis
Functions:
Therapeutic Monitoring
Companion Diagnostics
Prognostic Diagnostics
Cancer Screening
Risk Analysis
Regions:
North America
o U.S.
o Canada
Europe
o UK
o Germany
o France
Asia Pacific
o China
o India
o Japan
Rest of the World
Request Sample Report at https://www.wiseguyreports.com/sample-request/2742055-global-next-generation-cancer-diagnostics-market-size-study-by-technology
Furthermore, the years considered for the study are as follows:
Historical year – 2015
Base year – 2016
Forecast period – 2017 to 2025
Some of the key manufacturers involved in the market are; Novartis AG, F. Hoffmann-La Roche Ltd, Koninklijke Philips N.V., Abbott, GE Healthcare, Thermo Fisher Scientific, Inc.
Target Audience of the Next Generation Cancer Diagnostics Market Study
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Table of content
Chapter 1. Research Methodology
Chapter 2. Global Next Generation Cancer Diagnostics Market Definition & Scope
Chapter 3. Executive Summary
Chapter 4. Global Next Generation Cancer Diagnostics Industry Dynamics
Chapter 5. Global Next Generation Cancer Diagnostics Market by Technology
Chapter 6. Global Next Generation Cancer Diagnostics Market by Type
Chapter 7. Global Next Generation Cancer Diagnostics Market by Application
Chapter 8. Global Next Generation Cancer Diagnostics Market by Function
Chapter 9. Global Next Generation Cancer Diagnostics Market, Regional Analysis
Chapter 10. Competitive Intelligence
About Us:
Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.
Contact Us:
NORAH TRENT
Ph: +1-646-845-9349 (US)
Ph: +44 208 133 9349 (UK)
Your information will never be shared with any third party.